Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONNECT 1: Albuterol eMDPI Digital System in Asthma
NCT03890666Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of albuterol spiromax in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2020; status: completed.
02
Drugs
albuterol spiromax
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03890666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03890666.